Treatment of B-cell depleted COVID-19 patients with convalescent plasma and plasma-based products
Treatment of B-cell depleted COVID-19 patients with convalescent plasma and plasma-based products is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Treatment of B-cell depleted COVID-19 patients with convalescent plasma and plasma-based products have?
Treatment of B-cell depleted COVID-19 patients with convalescent plasma and plasma-based products has 35 citations in the OpenAlex counts ScholarIQ stores.
When was Treatment of B-cell depleted COVID-19 patients with convalescent plasma and plasma-based products published?
Treatment of B-cell depleted COVID-19 patients with convalescent plasma and plasma-based products has 2021 year in the ScholarIQ index.
What is the open-access status of Treatment of B-cell depleted COVID-19 patients with convalescent plasma and plasma-based products?
Treatment of B-cell depleted COVID-19 patients with convalescent plasma and plasma-based products has green oa status in the ScholarIQ index.
What is the DOI of Treatment of B-cell depleted COVID-19 patients with convalescent plasma and plasma-based products?
The DOI for Treatment of B-cell depleted COVID-19 patients with convalescent plasma and plasma-based products is on the source record.
What is the PMID of Treatment of B-cell depleted COVID-19 patients with convalescent plasma and plasma-based products?
The PMID for Treatment of B-cell depleted COVID-19 patients with convalescent plasma and plasma-based products is on the source record.
What is the OpenAlex record for Treatment of B-cell depleted COVID-19 patients with convalescent plasma and plasma-based products?
The OpenAlex for Treatment of B-cell depleted COVID-19 patients with convalescent plasma and plasma-based products is on the source record.